Michele P. Lambert

9.3k total citations · 3 hit papers
116 papers, 3.1k citations indexed

About

Michele P. Lambert is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, Michele P. Lambert has authored 116 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Hematology, 30 papers in Immunology and 26 papers in Genetics. Recurrent topics in Michele P. Lambert's work include Platelet Disorders and Treatments (80 papers), Blood groups and transfusion (35 papers) and Immunodeficiency and Autoimmune Disorders (20 papers). Michele P. Lambert is often cited by papers focused on Platelet Disorders and Treatments (80 papers), Blood groups and transfusion (35 papers) and Immunodeficiency and Autoimmune Disorders (20 papers). Michele P. Lambert collaborates with scholars based in United States, Canada and United Kingdom. Michele P. Lambert's co-authors include Terry Gernsheimer, Mortimer Poncz, M. Anna Kowalska, Jenny M. Despotovic, Ingmar Bruns, Yuya Kunisaki, Paul S. Frenette, Sandra Pinho, James B. Bussel and Daniel Lucas and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and Nature Communications.

In The Last Decade

Michele P. Lambert

112 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Megakaryocytes regulate hematopoietic stem cell quiescence through CXCL4 secretion

2014 452 citations Michele P. Lambert, Mortimer Poncz et al. profile →
Clinical updates in adult immune thrombocytopenia

2017 291 citations Michele P. Lambert et al. Blood profile →
Thrombocytopenia following Pfizer and Moderna SARS‐CoV‐2 vaccination

2021 270 citations Michele P. Lambert, James B. Bussel et al. American Journal of Hematology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michele P. Lambert United States	27	2.1k	719	535	463	418	116	3.1k
Margaret E. Rick United States	27	1.8k 0.9×	494 0.7×	467 0.9×	473 1.0×	313 0.7×	61	2.8k
Shinsuke Yasuda Japan	32	1.1k 0.5×	993 1.4×	228 0.4×	199 0.4×	474 1.1×	163	3.2k
Peter Kalhs Austria	34	2.4k 1.1×	1.1k 1.5×	248 0.5×	478 1.0×	325 0.8×	119	3.3k
Ronald H. W. M. Derksen Netherlands	37	2.6k 1.2×	1.5k 2.1×	525 1.0×	170 0.4×	426 1.0×	72	6.1k
Carrie Wagner United States	33	936 0.5×	1.8k 2.5×	656 1.2×	391 0.8×	538 1.3×	53	4.8k
Sudha Visvanathan United States	35	1.7k 0.8×	2.5k 3.5×	183 0.3×	638 1.4×	394 0.9×	71	5.4k
Meinolf Suttorp Germany	32	2.6k 1.2×	951 1.3×	230 0.4×	1.2k 2.6×	513 1.2×	184	4.0k
Kim Vettenranta Finland	31	1.0k 0.5×	290 0.4×	235 0.4×	249 0.5×	571 1.4×	167	3.4k
Martha Sola‐Visner United States	34	1.8k 0.8×	276 0.4×	234 0.4×	441 1.0×	523 1.3×	121	3.4k
Michele Falda Italy	25	1.8k 0.9×	660 0.9×	314 0.6×	885 1.9×	1.3k 3.1×	55	3.6k

Countries citing papers authored by Michele P. Lambert

Since Specialization

Citations

This map shows the geographic impact of Michele P. Lambert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele P. Lambert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele P. Lambert more than expected).

Fields of papers citing papers by Michele P. Lambert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele P. Lambert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele P. Lambert. The network helps show where Michele P. Lambert may publish in the future.

Co-authorship network of co-authors of Michele P. Lambert

This figure shows the co-authorship network connecting the top 25 collaborators of Michele P. Lambert. A scholar is included among the top collaborators of Michele P. Lambert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele P. Lambert. Michele P. Lambert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Grimes, Amanda B., Taizo A. Nakano, Robert J. Klaassen, et al.. (2025). Working toward international consensus defining pediatric “refractory ITP”. Blood Advances. 9(5). 1244–1245. 1 indexed citations

Doshi, Bhavya S., et al.. (2025). Diagnosis of platelet dysfunction in children: clinical predictors and test methods. PubMed. 3(1). 100135–100135.

Lambert, Michele P. & Theodore E. Warkentin. (2024). Mini-clusters of postadenovirus VITT. Research and Practice in Thrombosis and Haemostasis. 9(1). 102641–102641. 4 indexed citations

Dulmovits, Brian M., K. Taylor Wild, John Flibotte, et al.. (2023). Neonatal Thrombocytopenia as a Presenting Finding in de novo Pyruvate Kinase Deficiency. Neonatology. 120(5). 661–665.

Campbell, Ian M., T. Blaine Crowley, Chintan Jobaliya, et al.. (2022). Platelet findings in 22q11.2 deletion syndrome correlate with disease manifestations but do not correlate with GPIb surface expression. Clinical Genetics. 103(1). 109–113. 4 indexed citations

Lambert, Michele P.. (2021). Presentation and diagnosis of autoimmune lymphoproliferative syndrome (ALPS). Expert Review of Clinical Immunology. 17(11). 1163–1173. 13 indexed citations

Grace, Rachael F. & Michele P. Lambert. (2021). An update on pediatric ITP: differentiating primary ITP, IPD, and PID. Blood. 140(6). 542–555. 17 indexed citations

Ross, Justyne, Bing Zhang, Kristy Lee, et al.. (2021). Specifications of the variant curation guidelines for ITGA2B/ITGB3: ClinGen Platelet Disorder Variant Curation Panel. Blood Advances. 5(2). 414–431. 22 indexed citations

Shimano, Kristin A., Cindy Neunert, James B. Bussel, et al.. (2021). Quality of life is an important indication for second‐line treatment in children with immune thrombocytopenia. Pediatric Blood & Cancer. 68(6). e29023–e29023. 8 indexed citations

10.

Diorio, Caroline, Rawan Shraim, Laura A. Vella, et al.. (2021). Proteomic profiling of MIS-C patients indicates heterogeneity relating to interferon gamma dysregulation and vascular endothelial dysfunction. Nature Communications. 12(1). 7222–7222. 41 indexed citations

11.

Cuker, Adam, Jenny M. Despotovic, Rachael F. Grace, et al.. (2020). Tapering thrombopoietin receptor agonists in primary immune thrombocytopenia: Expert consensus based on the RAND/UCLA modified Delphi panel method. Research and Practice in Thrombosis and Haemostasis. 5(1). 69–80. 15 indexed citations

12.

Oved, Joseph H., Daria V. Babushok, Michele P. Lambert, et al.. (2020). Human mutational constraint as a tool to understand biology of rare and emerging bone marrow failure syndromes. Blood Advances. 4(20). 5232–5245. 7 indexed citations

13.

Lambert, Michele P., et al.. (2019). The Effect of "Pathway" to Diagnosis for Childhood ITP on Caregiver Quality of Life at Time of Diagnosis. Blood. 134(Supplement_1). 2174–2174. 1 indexed citations

14.

Grimes, Amanda B., et al.. (2019). Association of a positive direct antiglobulin test with chronic immune thrombocytopenia and use of second line therapies in children: A multi‐institutional review. American Journal of Hematology. 94(4). 461–466. 8 indexed citations

15.

Kruse, Caroline, et al.. (2018). The ITP Natural History Study Registry: Preliminary Findings on the Immune Thrombocytopenia Patient Experience. Blood. 132(Supplement 1). 4979–4979. 1 indexed citations

16.

Cohen, Jennifer L., T. Blaine Crowley, Daniel E. McGinn, et al.. (2018). 22q and two: 22q11.2 deletion syndrome and coexisting conditions. American Journal of Medical Genetics Part A. 176(10). 2203–2214. 21 indexed citations

17.

Samelson‐Jones, Benjamin J., Paula M. Kramer, Michael C. Chicka, William T. Gunning, & Michele P. Lambert. (2017). MYH9‐macrothrombocytopenia caused by a novel variant (E1421K) initially presenting as apparent neonatal alloimmune thrombocytopenia. Pediatric Blood & Cancer. 65(4). 2 indexed citations

18.

Bride, Karen L., et al.. (2017). Utility of the immature platelet fraction in pediatric immune thrombocytopenia: Differentiating from bone marrow failure and predicting bleeding risk. Pediatric Blood & Cancer. 65(2). 27 indexed citations

19.

Romasko, Edward J., Batsal Devkota, Sawona Biswas, et al.. (2017). Utility and limitations of exome sequencing in the molecular diagnosis of pediatric inherited platelet disorders. American Journal of Hematology. 93(1). 8–16. 22 indexed citations

20.

Lambert, Michele P., et al.. (2017). The 22q11.2 deletion syndrome: Cancer predisposition, platelet abnormalities and cytopenias. American Journal of Medical Genetics Part A. 176(10). 2121–2127. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact